local purchase of medicine as per tender documents , medicines , single piece pmma 13mm aciol power 15 . 0d to 20 . 0d , single piece pmma 13mm pciol power 15 . 0d to 25 . 0d , hydrodisscetion cannula ( disposable ) 27 g , triamcinolone acetate inj 40 mg/ml vial of 1 ml ( kenacort ) , hydrophobic aspheric monofocal heparin coated acrylic iol heptic diameter 6 mm a constant 119 . 8 power 16 . 0d to 24 . 0d , acrylic multi piece strile pcl ( iol/pc ) 13 . 0mm lenght 6 . 0mm anterior asymmetric biconvex optic monoflex ( tm* ) 10 degree heptics a constant 118 . 4 reg , u . s pat and tm off , hydrophobic acrylic single piece biconvex foldable iol with anterior toric aspheric surface aberratio -0 . 27microns , 360 degree posterior square edge uv blocking , optic size 6mm overall length 13mm , ri - 1 . 47 , usfda and ce approved , moxifloxacin 0 . 5% with drop tainer dispensing system with netural ph 6 . 8 osmolarity 290 mosm/kg with ldp bottle eye drop , tobramycin opth sol 300mg/5ml ( tobramycin 0 . 3% bott of 5 ml sulphate free ) , moxifloxacin of 5gm eye oint , azithromycin 5gm eye oint , ciprofloxacin hcl 0 . 3% tube of 5 gm eye oint , gatifloxacin 0 . 3% + prednisolone 1% eye drop 10ml , e/d gatifloxacin 0 . 3%+ketrolac 0 . 4% 5 ml , e/d gatifloxacin sesquihdrate ip , equivalent to gatifloxacin 0 . 3% w/v +loteprednol etabonate 0 . 5% w/v bak 0 . 005% w/v purified water 5 ml , e/d florometholone acetate 0 . 1% + tobramycin 0 . 3% with bak 0 . 005% bott of 5ml , e/oint ciprofloxacin + dexamethasone tube of 5 gm , e/d lotepredenol etabonate 0 . 5 bott of 5 ml , difluprednate opth0 . 5% bott of 5 ml eye drop , e/d florometholone acetate 0 . 1% +bak 0 . 004% + polyvinyl alchol 1 . 4% bott of 5 ml bott of 5ml , carboxy methyl cellulose 0 . 5% bott of 5-10 ml eye drop , hpmc 0 . 3% + dextran 700 . 1 % + with polyquad preservative and drop trainer system 10 ml eye drop , e/d naphazoline+ hydroxypropylmethaycellulose 0 . 05% bott of 10 ml , e/d carboxymethylcellulose 0 . 5%+ stabilized oxychlor complex 0 . 01% with glycerin , erythritol , levocarnitine , boric acid , calcium dehydrate , kcl , mgcl , sod citrate dehydrate bott of 10 ml , carboxy methyl cellulose 0 . 5% with purite bott of 5 ml eye drop , e/d nepafenac 0 . 3 % with cmc carbomer 970p& guar gum with drop tainer system bott of 3 ml , e/d ketrolac + tromethamine 0 . 4% , bak 0 . 006% 5 ml , polyethylene glycol 0 . 4% + propylene glycol 0 . 3% + hp gaur + borate + sorbitol bott of 10ml eye drop , e/d bromfenac 0 . 09% w/v benzalkonium chloride solution ip 0 . 02% v/v saline aqueous base q . s . bott of 5 ml , flurbiprofen sodium ophthalmic sol 0 . 3% vial of 5 ml , natamycin 3% in 3 ml eye drops , e/d olopatadine 0 . 2% with drop triner system 2 . 5ml , e/d azelastine 1% bott of 5 ml , e/d olopatadine hydrochroride 0 . 1% + ketrolac tromethamine 0 . 4% bott of 5 ml , homatropine hydrochloride , sol 2% eye drop 5ml , cyclopentolate hcl 1% opth soln bottle of 5 ml , tropicamide 0 . 8% , phenylephrine hcl 5% eye drops bott of 5ml eye drop , e/d brimonidine tartrate 0 . 1% w/v + stablized oxychloro complex with purite , cmc , sodium cloride , potassium chloride , calcium dihydrate , magnesium hexahydarte 5 ml , e/d travoprost 0 . 004%+ with polyqad preservative and mannitol 2 . 5 ml , bimatoprost 0 . 03% bott of 3ml , e/d brinzolamide 1%with manitol and dorp traner bott of 5 ml , e/d latanoprost 0 . 005% with drop applicator system bott of 2 . 5 ml , latanoprost 0 . 005% with 0 . 5% timolol eye drop bott of 2 . 5 ml , e/d travoprost 0 . 004% + timolol 0 . 5% with polyquad preservative and manitol 2 . 5 ml , e/d brimonidine tartrate 0 . 2% w/v + timolol 0 . 5% + benzalkonium chloride 0 . 05% ( bak ) usfda approved with iit packing 5 ml , e/d dorzolamide 2% 5 ml , dorzolamide 2% + timolol 0 . 5% eye drop , e/d bimatoprost 0 . 3% + timolol 0 . 5% + benzalkonium chloride ( bak ) 0 . 005% 3 ml , sodium chloride 6% w/w ointment tube of 3 gm , proparacaine 0 . 5% eye drop bott of 5 ml , e/d sodium chloride drops 5% bott of 5 ml , cyclosporine eye drop 0 . 05% bott of 5 ml , tab anti oxidant ( lutrin 5 mg zeaxanthine 1 mg , omega 3 fatty acid 500 mg , chocoberry extract 50 mg , vit c mg , vit e1 u , zinc 1 mg selenium 7 . 5 mg , omega 9 omega 3 fatty acid 500 mg 325 mg epa + 175 mg dha tab , fluorescein 3 ml inj , inj pilocarpine intracameral 0 . 5% , pilocarpine nitrate 2 ml , hyaluronidase 1500 iu inj , disposable needle s-26 , eye pad with sterilized adhesive bandage usp , drape , surgical disposable for eye surgery , balanced salt sterile opthalmic irrigating solution 500ml , trypan blue 0 . 6% in vial of 1 ml inj , post operative protective glasses ( black ) , ear/eye buds pkt of 100 , tissue adhesive cyno acrylic fibrin glu , surg blade 2 . 8 mm with electropolished ( with electritiching tech ) , surg blade 15 degree with electropolished ( with electritiching tech ) , suture 3/0 mersilk atraumatic , brimonidine tartrate 0 . 1% with purite cmc , sodium chloride , potassium chloride , calcium dihydrate , magnesium hexahydrate bott of 5 ml eye drop , fluconazole 0 . 3% w/v bott of 5 ml eye drop , gatifloxacin 0 . 3% eye drop bott of 5 ml , moxifloxacin 0 . 5% preservative free eye drops , chlorhexidine gluconate solution in soap , 4% w/v for surgical hand scrub , 500ml bott , en tested , e/d prednisolone1 % 5ml , inj sod hyaluronate oph sole 40 mg with chondroitin sulphate 17 mg in pfs 0 . 75 ml , disposable irrigation and aspiration hand piece bimannual system , dry amniotic membrane 3mm x 3mm , suture polyamide 10/0 with double ended 6 . 5 mm spatula curved cutting needle , eye drop ripasudil 0 . 4% w/v 5 ml , balanced salt sterile opthalmic irrigating solution 250ml , disposal sterile trolley cover , eye drop moxifloxacin 0 . 5% + difluprednate 0 . 05% of 5 ml , e/d olopatadine hydrochroride 0 . 1% bott of 5 ml , 30 g needle , suture 8/0 vicryl with taperred cutting double ended , suture polyamide 6/0 with double ended 6 . 5 mm spatula curved cutting needle , suture polyamide 8/0 with double ended 6 . 5 mm spatula curved cutting needle